IN Brief:
- Mondelēz has warned that shifting UK food regulation could affect future investment decisions.
- The company has spent £40m reformulating products to comply with HFSS rules that later changed.
- The comments highlight manufacturer concern over nutrition policy, UPF scrutiny, and reformulation economics.
Mondelēz International chief executive Dirk Van de Put has warned that unstable UK food regulation could affect the company’s future investment in the country, as confectionery and snack manufacturers continue to navigate HFSS restrictions, ultra-processed food scrutiny, and reformulation costs.
Van de Put said the UK is Mondelēz’s second biggest country, making it too important to ignore, but argued that a shifting regulatory environment creates doubts over future investment. The comments follow a period of global disruption for the group, including inflation, war-related instability, and damage to facilities in Ukraine and Bahrain.
The company behind Cadbury, Oreo, Toblerone, and Ritz has already spent £40m reformulating products to comply with high fat, salt, and sugar rules. Van de Put said that money had been spent against requirements that subsequently changed, creating direct cost without a stable policy framework around it.
The warning points to a wider investment question for UK food manufacturing. Companies must plan product development, line trials, packaging changes, retailer formats, marketing restrictions, and capital spending while nutrition rules, advertising rules, and definitions around less healthy foods remain contested.
HFSS regulation affects products across confectionery, snacks, bakery, dairy desserts, soft drinks, and prepared foods. Reformulation can alter processing behaviour, shelf life, texture, flavour release, consumer acceptance, allergen position, ingredient cost, label claims, packaging, and production efficiency. A change that solves one regulatory issue can create several technical problems elsewhere.
Mondelēz’s warning also reflects the increasing overlap between HFSS policy and the debate around ultra-processed foods. Van de Put criticised the lack of clarity around UPF definitions, arguing that businesses are being asked to respond to a discussion that has not yet settled scientifically or practically. Manufacturers face a difficult balance: reduce sugar, fat, or salt, while avoiding ingredient substitutions that attract further criticism for appearing more processed.
The pressure is not confined to confectionery. Compliance questions around delayed UK energy drink restrictions continue to sit alongside innovation in indulgent categories, including Pladis extending McVitie’s Jaffa into soft-baked cookie formats. The market is still launching, extending, and premiumising, even as policy pressure rises.
Regulatory uncertainty can push product development toward caution. If manufacturers cannot predict which products, promotions, locations, claims, or formats will be allowed, investment decisions become slower and more defensive. That affects multinational brand owners, ingredient suppliers, co-manufacturers, packaging converters, equipment suppliers, and retailers that depend on launch pipelines.
Reformulation also carries an opportunity cost. A £40m programme directed toward compliance may still deliver useful technical learning, but it competes with investment in capacity, automation, sustainability, new product development, packaging transition, and supply-chain resilience. In high-volume manufacturing, those trade-offs matter because capital and technical teams are finite.
Products with long development cycles are especially exposed. A manufacturer may need to reformulate, test shelf life, validate safety, run plant trials, adjust packaging, update labelling, renegotiate retailer listings, and build stock before a regulatory deadline. When rules change midstream, that process can become stranded cost.
Public health pressure is unlikely to disappear. Governments are under pressure to address obesity, children’s diets, sugar intake, and the marketing of less healthy foods. Stronger manufacturers will need formulation, processing, and packaging systems that can adjust more flexibly, rather than relying on a single compliance route.
That places more importance on ingredient technology, portion control, sensory science, data-led reformulation, and line flexibility. It also increases the value of early regulatory intelligence, because a small change in scoring or category rules can alter whether a product is commercially viable in a particular channel.
Mondelēz’s warning shows nutrition regulation moving into capital planning. Compliance is no longer limited to labels and claims. It can influence where money is spent, which products reach the market, and how much risk a company is willing to carry in the UK.
